CALL - SPRINTER OPEN END - MERCK & CO. Share Price

Certificat

DE000VM54310

Delayed Deutsche Boerse AG 11:34:19 25/06/2024 pm IST
2.87 EUR +2.87% Intraday chart for CALL - SPRINTER OPEN END - MERCK & CO.
Current month+36.02%
1 month+13.44%
Date Price Change
25/24/25 2.87 +2.87%
24/24/24 2.79 +8.56%
21/24/21 2.57 -1.53%
20/24/20 2.61 +12.50%
19/24/19 2.32 -4.13%

Delayed Quote Deutsche Boerse AG

Last update June 25, 2024 at 11:34 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM5431
ISINDE000VM54310
Date issued 29/11/2023
Strike 102.9 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.12
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.91
Lowest since issue 0.195
Spread 0.08
Spread %2.76%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
132.9 USD
Average target price
142.7 USD
Spread / Average Target
+7.34%
Consensus